Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study
-
Published:2021-12
Issue:6
Volume:6
Page:100328
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Tabernero J.ORCID,
Velez L.,
Trevino T.L.,
Grothey A.ORCID,
Yaeger R.ORCID,
Van Cutsem E.ORCID,
Wasan H.ORCID,
Desai J.ORCID,
Ciardiello F.ORCID,
Yoshino T.ORCID,
Gollerkeri A.ORCID,
Maharry K.,
Christy-Bittel J.,
Kopetz S.ORCID
Subject
Cancer Research,Oncology
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献